ESTRO 2022 - Abstract Book

DIGITAL POSTERS Education in Radiation Oncology................................................................................................................ (abs. 1030 - 1034) Health economics / health services research............................................................................................ (abs. 1035 - 1054) Other.............................................................................................................................................................. (abs. 1055 - 1072) Head and neck.............................................................................................................................................. (abs. 1073 - 1122) CNS................................................................................................................................................................. (abs. 1123 - 1169) Haematology................................................................................................................................................. (abs. 1170 - 1174) Breast............................................................................................................................................................. (abs. 1175 - 1238) Lung............................................................................................................................................................... (abs. 1239 - 1281) Upper GI........................................................................................................................................................ (abs. 1282 - 1310) Lower GI. ....................................................................................................................................................... (abs. 1311 - 1329) Gynaecological.............................................................................................................................................. (abs. 1330 - 1357) Biomarkers.................................................................................................................................................... (abs. 1358 - 1362) Urology.......................................................................................................................................................... (abs. 1363 - 1426) Sarcoma/Skin cancer/malignant melanoma.............................................................................................. (abs. 1427 - 1438) Paediatric tumours................................................................................................................................................... (abs. 1439) Mixed sites/palliation................................................................................................................................... (abs. 1440 - 1476) Inter-fraction motion management and offline adaptive radiotherapy ................................................. (abs. 1477 - 1493) Applications of ion beam treatment planning........................................................................................... (abs. 1494 - 1509) Applications of photon and electron treatment planning........................................................................ (abs. 1510 - 1523) Dosimetry...................................................................................................................................................... (abs. 1524 - 1590) Imaging acquisition and processing........................................................................................................... (abs. 1591 - 1633) Implementation of new technology and techniques................................................................................ (abs. 1634 - 1687) Intra-fraction motion management and real-time adaptive radiotherapy............................................. (abs. 1688 - 1723) Optimisation and algorithms for ion beam treatment planning............................................................. (abs. 1724 - 1731) Optimisation and algorithms for photon and electron treatment planning.......................................... (abs. 1732 - 1747) Physical aspects of quantitative functional and biological imaging........................................................ (abs. 1748 - 1754) Radiomics, modelling and statistical methods.......................................................................................... (abs. 1755 - 1789) Brachytherapy: Breast. ............................................................................................................................................ (abs. 1790) Brachytherapy: Gynaecology....................................................................................................................... (abs. 1791 - 1800) Brachytherapy: Physics................................................................................................................................ (abs. 1801 - 1806) Brachytherapy: Head and neck, skin, eye.................................................................................................. (abs. 1807 - 1812) Brachytherapy: Urology (prostate, bladder, penile).................................................................................. (abs. 1813 - 1819) Normal tissue radiobiology......................................................................................................................... (abs. 1820 - 1823) Tumour radiobiology. .................................................................................................................................. (abs. 1824 - 1825) Immuno-radiobiology. ................................................................................................................................. (abs. 1826 - 1828) Patient preparation, positioning and immobilisation............................................................................... (abs. 1829 - 1853) RTT education, training, advanced practice and role developments...................................................... (abs. 1854 - 1861) RTT service evaluation, quality assurance and risk management........................................................... (abs. 1862 - 1870) RTT treatment planning, OAR and target definitions ................................................................................ (abs. 1871 - 1893)